- Home
- CRMD vs HPS Comparison
CRMD vs HPS Comparison
Compare CRMD & HPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRMD
- HPS
- Stock Information
- Founded
- CRMD 2006
- HPS 2003
- Country
- CRMD United States
- HPS United States
- Employees
- CRMD N/A
- HPS N/A
- Industry
- CRMD Biotechnology: Pharmaceutical Preparations
- HPS Investment Managers
- Sector
- CRMD Health Care
- HPS Finance
- Exchange
- CRMD Nasdaq
- HPS Nasdaq
- Market Cap
- CRMD 626.8M
- HPS 521.2M
- IPO Year
- CRMD 2010
- HPS N/A
- Fundamental
- Price
- CRMD $10.33
- HPS $15.53
- Analyst Decision
- CRMD Strong Buy
- HPS
- Analyst Count
- CRMD 5
- HPS 0
- Target Price
- CRMD $15.20
- HPS N/A
- AVG Volume (30 Days)
- CRMD 1.6M
- HPS 58.4K
- Earning Date
- CRMD 10-30-2024
- HPS 01-01-0001
- Dividend Yield
- CRMD N/A
- HPS 8.62%
- EPS Growth
- CRMD N/A
- HPS N/A
- EPS
- CRMD N/A
- HPS N/A
- Revenue
- CRMD $12,262,234.00
- HPS N/A
- Revenue This Year
- CRMD N/A
- HPS N/A
- Revenue Next Year
- CRMD $277.75
- HPS N/A
- P/E Ratio
- CRMD N/A
- HPS N/A
- Revenue Growth
- CRMD 41184.20
- HPS N/A
- 52 Week Low
- CRMD $2.89
- HPS $11.79
- 52 Week High
- CRMD $13.85
- HPS $15.40
- Technical
- Relative Strength Index (RSI)
- CRMD 47.20
- HPS 32.45
- Support Level
- CRMD $10.16
- HPS $15.44
- Resistance Level
- CRMD $11.41
- HPS $16.45
- Average True Range (ATR)
- CRMD 0.73
- HPS 0.19
- MACD
- CRMD -0.18
- HPS -0.03
- Stochastic Oscillator
- CRMD 31.00
- HPS 5.35
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.
About HPS John Hancock Preferred Income Fund III Preferred Income Fund III
John Hancock Preferred Income Fund III is a closed-end, diversified management investment company. Its investment objective is to provide a high level of current income consistent with preservation of capital. The fund's secondary investment objective is to provide growth of capital to the extent consistent with its primary investment objective. It seeks to achieve the objectives by investing a majority of its assets in preferred stocks and other preferred securities, including convertible preferred securities. The portfolio composition of the company consists of the U.S. preferred securities, foreign preferred securities, common stocks, corporate bonds, and the short-term investments.